Delivery Order SPE2DB22D1202-SPE2DB24FVLU0

Award Date 8/22/24
Potential Completion Date 8/23/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Icosapent Ethyl 1 gram capsules. The contract has a ceiling value of $13,274.69 and a completion date of May 16, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive global...
This federal contract award is for the delivery of Icosapent Ethyl 1 gram capsules, a pharmaceutical product, to the Defense Logistics Agency (DLA). The fixed-price delivery order has a ceiling value of $1,306.03 and an ultimate completion date of April 17, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is not a set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Icosapent Ethyl 1 Gram Capsule 120s, with a ceiling value of $2,053.92 and a completion date of June 10, 2025. The contract is not set aside and is an open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,207,947 units of the medication Icosapent Ethyl 1 Gram Capsule 120s. The contract has a firm fixed price of $2,199.21 and a period of performance through May 12, 2025. The contract is not set aside and was awarded on May 11, 2025. AmerisourceBergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,871.58 firm fixed-price delivery order is for the supply of 120-count capsules of the drug Icosapent Ethyl 1 gram. The contract has an ultimate completion date of December 4, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This federal contract award, valued at $2,664.83, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Icosapent Ethyl 1 gram capsules (120 count). The award has a completion date of January 31, 2023 and is structured as a firm fixed-price delivery order. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp, a for-profit organization registered in the System for Award...
This federal contract award is for the delivery of Icosapent Ethyl 1 gram capsules to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $1,904.24 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of May 7, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,232.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a cardiovascular medication. This is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a...
This federal contract award is for the delivery of 120 count 1 gram capsules of Icosapent Ethyl, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award, valued at $1,132.46, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 7, 2023. The contract has a final completion date of November 8, 2023 and is structured as a firm fixed-price delivery order. No set-aside designations were used for this award. Amerisourcebergen Drug Corp is a...
This federal contract award is for the delivery of Icosapent Ethyl 1 gram capsules, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution company. The contract has a ceiling value of $1,323.73 and a completion date of December 11, 2023. It is a firm-fixed-price delivery order contract, awarded on December 8, 2022. The contract is not...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FVLU0
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4565550845 Icosapent Ethyl 1 gram capsule bottles. The contract has a total ceiling value of $1,668.12 and is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025. This IDC enables DLA Troop Support Medical to efficiently procure a comprehensive range of medical commodities, including prescription drugs and supplies, to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is scheduled for completion by August 23, 2024.

Generated 11/21/24, 9:40 AM